高效抗逆转录病毒治疗与伽玛刀放射外科治疗艾滋病相关原发性中枢神经系统淋巴瘤
一例66岁男性艾滋病相关原发性中枢神经系统淋巴瘤患者,CD4计数21 cells/μL、HIV病毒载量>400,000 copies/mL,接受高效抗逆转录病毒治疗后拒绝全脑放疗,接受伽玛刀放射外科治疗右侧颞叶病灶;3个月时神经症状改善、CD4升至176 cells/mL、病毒载量<90 copies/mL,12个月无症状,36个月MRI示完全缓解。作者认为新诊断PCNSL的标准治疗仍为大剂量化疗联合姑息性全脑放疗,但化疗、HAART与GKRS联合方案可能对艾滋病相关PCNSL生存率有积极影响。
要点
- 艾滋病相关PCNSL患者可表现为头痛、定向障碍和嗜睡,影像示右颞叶为主的多发病灶。
- 本例CD4 21 cells/μL、HIV病毒载量>400,000 copies/mL,接受HAART后CD4升至176 cells/mL、病毒载量<90 copies/mL。
- 本例拒绝全脑放疗,接受GKRS后3个月神经症状改善,36个月MRI示完全缓解。
核心结论
- 新诊断PCNSL的标准治疗仍为大剂量化疗联合姑息性全脑放疗,但化疗、HAART与GKRS联合方案可能对艾滋病相关PCNSL生存率有积极影响。
研究设计与样本
- 个案报告:一例66岁男性艾滋病相关原发性中枢神经系统淋巴瘤患者。
主要发现
- 脑MRI示右颞叶为主的多发非特异性病灶,活检诊断为PCNSL。
- 实验室检查示活动性HIV感染,CD4计数21 cells/μL,HIV病毒载量>400,000 copies/mL。
- 接受HAART后3个月,CD4计数升至176 cells/mL,HIV病毒载量<90 copies/mL。
- 接受GKRS治疗右颞叶病灶后3个月神经症状改善,12个月无症状,36个月MRI示完全缓解且无新发病灶。
临床怎么用
- 作者认为新诊断PCNSL的标准治疗仍为大剂量化疗联合姑息性全脑放疗,但化疗、HAART与GKRS联合方案可能对艾滋病相关PCNSL生存率有积极影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The criterion standard for the treatment of newly diagnosed primary central nervous system lymphoma (PCNSL) remains high-dose chemotherapy in conjunction with palliative whole-brain radiotherapy; however, there may be a role for novel combined approaches in immunocompromised patients. CASE DESCRIPTION: A 66-year-old man presented with acute cephalalgia, disorientation, and lethargy. His condition was evaluated in the emergency department, and he was admitted with probable hydrocephalus. Magnetic resonance imaging (MRI) of the brain revealed multiple nonspecific brain lesions, predominantly involving the right temporal lobe, which on biopsy led to a diagnosis of PCNSL. Subsequent laboratory studies demonstrated active human immunodeficiency virus (HIV) infection, with a CD4 count of 21 cells/μL and an HIV viral load (VL) of >400,000 copies/mL. The patient was eventually given highly active antiretroviral therapy (HAART). He declined palliative whole-brain radiotherapy but was amenable to gamma knife radiosurgery (GKRS) for treatment of the right temporal brain lesions. Three months later, the patient's neurologic symptoms had improved; similarly, his CD4 count increased to 176 cells/mL, and his HIV viral load was <90 copies/mL. By the 12-month follow-up visit, the patient was asymptomatic, and at 36 months, MRI of the brain demonstrated total remission without new brain lesions. CONCLUSIONS: The criterion standard for treatment of newly diagnosed PCNSL remains high-dose chemotherapy in conjunction with palliative whole-brain radiotherapy; however, there may be a role for novel combined approaches using chemotherapy, HAART, and GKRS to have a positive impact on survival rates of PCNSL related to AIDS.
引用
- Alvarez-Pinzon AM, Valerio JE, Swedberg HN, et al. Highly Active Antiretroviral Therapy and Gamma Knife Radiosurgery for the Treatment of AIDS-Related Primary Central Nervous System Lymphoma. World Neurosurg. 2019. PMID: 30654158. doi:10.1016/j.wneu.2018.12.182
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。